GDRX Q3 2022 Earnings — GoodRx Holdings, Inc. Revenue & Financial Results | Market Cap Arena

GDRXGoodRx Holdings, Inc.

$829M

Q3 2022 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$187M-4.0% YoY

Gross Profit

$170M90.7% margin

Operating Income

-$16M-8.4% margin

Net Income

-$42M-22.3% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

-2.3%

Cash Flow

Operating Cash Flow

$34M

Free Cash Flow

$20M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$779M

Stockholders' Equity

$788M

Cash & Equivalents

$729M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$187M	$195M	-4.0%
Gross Profit	$170M	$184M	-7.6%
Operating Income	-$16M	$7M	-324.5%
Net Income	-$42M	-$18M	-131.0%

Revenue Segments

Prescription Transactions Revenue

$131M70%

Subscription Revenue

$26M14%

Pharma Manufacturer Solutions Revenues

$24M13%

Other Revenue

$5M3%